Cargando…

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses

Detalles Bibliográficos
Autores principales:	Wild, J, Köstler, J, Bredl, S, Böckl, K, Kindsmüller, K, Wagner, R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767862/ http://dx.doi.org/10.1186/1742-4690-6-S3-P352

Ejemplares similares

Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA Vaccine
por: Böckl, Katharina, et al.
Publicado: (2012)

P10-10. HIV-1 Gag virus like particles pseudotyped with CD40 ligand to stimulate innate immune responses
por: Köstler, J, et al.
Publicado: (2009)

P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
por: Nabi, G, et al.
Publicado: (2009)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
por: Fellay, J, et al.
Publicado: (2009)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
por: Gabitzsch, ES, et al.
Publicado: (2009)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
por: Hopkins, Kathryn L., et al.
Publicado: (2014)

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen
por: Herath, S., et al.
Publicado: (2015)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

Endogenous retrovirus type W GAG and ENV antigenaemia in serum of schizophrenic patients
por: Bernard, Corinne, et al.
Publicado: (2009)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
por: Kyosiimire-Lugemwa, J, et al.
Publicado: (2009)

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
por: Janes, Holly, et al.
Publicado: (2012)

HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins
por: Brumme, Zabrina L., et al.
Publicado: (2009)

A purine-rich element in foamy virus pol regulates env splicing and gag/pol expression
por: Moschall, Rebecca, et al.
Publicado: (2017)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

Expression of Gag and Pol from reconstructed HERV-Fc1, associated with multiple sclerosis
por: Nissen, Kari K, et al.
Publicado: (2011)

Coordinated changes of HIV-1 Gag and Env during assembly and maturation
por: Kräusslich, Hans-Georg
Publicado: (2013)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2015)

Placement of p6pol between tandem repeat HIV-1 protease domains reduces Gag cleavage efficiency
por: Chou, Tin-An, et al.
Publicado: (2013)

N-terminal foamy virus Gag domains and individual residues are critical for capsid assembly and interaction with the unique Env leader protein Elp for Env-dependent budding
por: Liu, Yang, et al.
Publicado: (2013)

P17-14. Fitness-informed HIV-1 Gag-p24 vaccine design
por: Rolland, MM, et al.
Publicado: (2009)

Yeast surface display of HIV Env protein variants for the discovery of novel vaccine immunogens
por: Grimm, S, et al.
Publicado: (2012)

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
por: Hulot, SL, et al.
Publicado: (2012)

GagPol-specific CD4(+) T-cells increase the antibody response to Env by intrastructural help
por: Nabi, Ghulam, et al.
Publicado: (2013)

P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV
por: Xie, J, et al.
Publicado: (2009)

Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques
por: Valentin, Antonio, et al.
Publicado: (2015)

FRET analysis of HIV‐1 Gag and GagPol interactions
por: Takagi, Shimon, et al.
Publicado: (2017)

Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines
por: Yan, J, et al.
Publicado: (2012)

HIV Pol Inhibits HIV Budding and Mediates the Severe Budding Defect of Gag-Pol
por: Gan, Xin, et al.
Publicado: (2012)

Correction: GagPol-specific CD4(+) T-cells increase the antibody response to Env by intrastructural help
por: Nabi, Ghulam, et al.
Publicado: (2013)

Development of chimeric HIV Env immunogens for mucosal delivery with attenuated canine distemper virus (CDV) vaccine vectors
por: Zhang, X, et al.
Publicado: (2012)

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime
por: Bauer, A, et al.
Publicado: (2012)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

Understanding the nature of the Nef requirement for HIV-1 infectivity
por: Rosa, Annachiara, et al.
Publicado: (2013)

HIV-1 Nef targets calnexin: a novel mechanism behind Nef effects on host cell and viral proteins
por: Jennelle, Lucas, et al.
Publicado: (2013)

Use of a High Resolution Melting (HRM) Assay to Compare Gag, Pol, and Env Diversity in Adults with Different Stages of HIV Infection
por: Cousins, Matthew M., et al.
Publicado: (2011)

Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance
por: Korniy, Natalia, et al.
Publicado: (2019)

Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
por: Lin, Yi-Ru, et al.
Publicado: (2022)

HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
por: Sauter, Daniel, et al.
Publicado: (2011)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
por: Singh, V, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kfhji7u5hgct5ubq22srf2qqb1